Company Monitoring Page for Vivus

latest headlines for company on cafepharma

Biotech 2012 Kickoff Party: Investor Preview
TheStreet.com
Wed, 01/4/12 - 10:22 am
Tags:
Celgene, Vivus, Dendreon, Gilead, Incyte, YM BioSciences, ONYX Pharmaceuticals, Seattle Genetics, Vertex, Amarin, Biomarin, Biogen Idec, Regeneron, Merck KGaA, Human Genome Sciences, Clovis Oncology, Roche, Ariad, Immunogen, Medivation, Geron, InterMune, Indenix, Amag Pharmaceuticals, Mesoblast, Arena, MannKind, Keryx, Spectrum Pharmaceuticals
FDA panel to review Qnexa in February 2012
Drug Store News
Fri, 12/23/11 - 08:59 am
Tags:
FDA, advisory panels, obesity, Qnexa, Vivus
Biotech Stock Mailbag: Most Important Events for 2012
TheStreet.com
Fri, 12/23/11 - 08:56 am
Tags:
Oncothyreon, Keryx, Vical, Aeterna Zentaris, Eli Lilly, JNJ, Elan, Celgene, Pfizer, Gilead, Pharmasset, Threshold Pharmaceuticals, Celldex, Amgen, BioVex, Aveo Pharmaceutical, Amylin, Alkermes, Vertex, Cell Therapeutics, Amarin, ONYX Pharmaceuticals, Vivus
6 Biotech Stocks With Consistently Rising Liquidity
Seeking Alpha
Fri, 12/23/11 - 08:49 am
Tags:
Enzon, Immunogen, Micromet, Oncothyreon, Vivus, QLT
Vivus falls 15% on drug safety study
Marketwatch
Thu, 12/22/11 - 02:44 pm
Tags:
Vivus, Qnexa
Vivus: analysis links ingredient of weight loss drug Qnexa to greater risk of birth defects
Yahoo/AP
Wed, 12/21/11 - 09:09 pm
Tags:
Qnexa, birth defects, Vivus
22 Hot Drugs Facing FDA Approval in 2012
TheStreet.com
Tue, 11/29/11 - 09:09 am
Tags:
Amarin, AMR101, Ironwood, linaclotide, Merck, Ariad, ridaforolimus, Vivus, Qnexa, Avanafil, Amgen, Xgeva, Cell Therapeutics, pixantrone, Kalydeco, Vertex, ONYX Pharmaceuticals, Carfilzomib, Pfizer, Bristol-Myers Squibb, Eliquis, Chelsea Therapeutics, Northera, Levadex, MAP Pharmaceuticals, Roche, Curis, vismodegib, Biogen Idec, Elan, Tysabri, Amylin, Bydureon, Dapagliflozin, Uplypso, Protalix BioTherapeutics, Teva Pharmaceuticals, BioSante, Bio-T-Gel, Corlux, Corcept Therapeutics, Discovery Labs, Surfaxin
Market Crash = Biotech Carnage
Motley Fool
Thu, 11/10/11 - 01:05 pm
Tags:
biotech, Zalicus, Complete Genomics, Pacific Biosciences, Illumina, Arena, Vivus
Vivus Posts Narrower Loss
Yahoo/Zacks.com
Tue, 11/8/11 - 10:33 am
Tags:
earnings, Vivus
Vivus says FDA accepts weight-loss drug application
Reuters
Fri, 11/4/11 - 09:24 am
Tags:
FDA, obesity, Vivus, Qnexa
Vivus Resubmits Qnexa Obesity Drug After Birth-Defect Warning
Bloomberg
Mon, 10/17/11 - 09:30 am
Tags:
warnings, Vivus, Qnexa, FDA, obesity
Two-year Treatment With Qnexa Has Benefits Beyond Weight Loss
Yahoo
Mon, 10/3/11 - 11:15 am
Tags:
Qnexa, obesity, Vivus
Arena Pharmaceuticals Shares Popped: What You Need to Know
Motley Fool
Sat, 09/17/11 - 02:52 pm
Tags:
Arena Pharmaceuticals, Orexigen, Vivus, Qnexa, weight loss, obesity
A Shrinking Obesity Market
Motley Fool
Sat, 09/17/11 - 02:51 pm
Tags:
weight loss, Vivus, Qnexa, Orexigen, Arena Pharmaceuticals
Vivus plans to resubmit potential diet pill Qnexa to FDA next month
Yahoo/AP
Thu, 09/15/11 - 11:52 am
Tags:
obesity, Vivus, FDA, Qnexa
Vivus says FDA accepts application on ED drug
Yahoo/AP
Fri, 09/2/11 - 02:13 pm
Tags:
FDA, Vivus, erectile dysfunction, Avanafil
Vivus to raise $45.8M in direct offering
Bizjournals.com
Tue, 08/23/11 - 07:27 pm
Tags:
Vivus, stock offering
Lower Spend Narrows Loss at Vivus
Yahoo/Zacks.com
Tue, 08/9/11 - 10:11 am
Tags:
Vivus, earnings
VIVUS Submits New Drug Application for Avanafil for the Treatment of Erectile Dysfunction
Yahoo
Thu, 06/30/11 - 08:18 am
Tags:
Vivus, Avanafil, erectile dysfunction
Vivus' ED Drug on Track
Yahoo/Zacks.com
Wed, 06/22/11 - 10:29 am
Tags:
Vivus, Avanafil, erectile dysfunction, GSK, Pfizer, Viagra, Levitra

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.